Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06673433

The Effects of Environmental Factors on the Macro-genome and Metabolism of Obese Patients.

The Effect of Environmental Factors on the Macro-genome and Metabolism of Obese Patients.

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Dong Peng · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The present study was designed to include obese patients diagnosed with obesity in the First Affiliated Hospital of Chongqing Medical University and a healthy control population. By analysing the relationship between metabolic parameters and macrogenomes in obesity, identifying key metabolic and macrogenomic differences between obese patients and healthy populations, and establishing the association between environmental factors and obesity-related metabolic disorders, the investigators will be able to provide new biomarkers and intervention targets for obesity prevention and treatment.

Detailed description

Obese patients who attended the First Hospital of Chongqing Medical University and intended to undergo bariatric surgery were screened according to the inclusion and exclusion criteria. Patients' basic personal information and biological specimens including blood, faeces and urine were collected for metabolic and macro-genomic analyses. Air pollution exposure of the study subjects was collected by telephone follow-up. Metabolite profiles in blood and urine were analysed using liquid chromatography-mass spectrometry (LC-MS). Microbial community composition in faecal samples was analysed using 16S rRNA gene sequencing. Metabolic and macrogenomic differences between obese and control groups were compared using t-test or Mann-Whitney U-test. Logistic regression analyses were used to assess the independent effects of different environmental factors on metabolism and macrogenome. Identify key metabolites and microorganisms associated with obesity using Random Forest and Principal Component Analysis.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTobesityPatients diagnosed with obesity (BMI ≥ 28kg/m2)
DIAGNOSTIC_TESThealththe health control group include paticipants with nomal BMI

Timeline

Start date
2022-10-01
Primary completion
2025-08-01
Completion
2025-12-01
First posted
2024-11-04
Last updated
2025-06-02

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06673433. Inclusion in this directory is not an endorsement.